Definitions

from The American Heritage® Dictionary of the English Language, 5th Edition.

  • noun A chimeric monoclonal antibody used to treat certain types of non-Hodgkin's lymphoma and refractory rheumatoid arthritis.

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A chimeric monoclonal antibody against the protein CD20, used in the treatment of lymphomas, leukemias, and some autoimmune disorders.

Etymologies

from The American Heritage® Dictionary of the English Language, 4th Edition

[ri-, origin unknown + tu(mor) + -xi- (alteration of chi(meric), influenced by X, Greek letter chi) + m(onoclonal) a(nti)b(ody).]

from Wiktionary, Creative Commons Attribution/Share-Alike License

-tu- +‎ -xi- +‎ -mab

Examples

  • Rituxan, known generically as rituximab, is made by Genentech, a unit of Roche Holding AG and Biogen Idec Inc.

    Boing Boing

  • Newer therapies are emerging as more promising, perhaps the most impressive of which is Rituxan, also known as rituximab, now being used to treat those with multiple sclerosis and other autoimmune diseases.

    The Autoimmune Epidemic

  • Newer therapies are emerging as more promising, perhaps the most impressive of which is Rituxan, also known as rituximab, now being used to treat those with multiple sclerosis and other autoimmune diseases.

    The Autoimmune Epidemic

  • MabThera, sold in the U.S. by Genentech Inc. under the brand name Rituxan and generically known as rituximab, is Roche's best-selling drug.

    Roche Drug Slows Leukemia

  • In March this year, Nice issued new guidance recommending the use of a drug called rituximab (MabThera), but saying adalimumab (Humira), etanercept (Enbrel) and infliximab (Remicade) could only be used in the context of research, even for those patients who had failed on one anti-TNF.

    icLiverpool

  • TLR4 was also found to be associated with the response to rituximab, which is used in the treatment of many lymphomas, leukemias, and some autoimmune disorders

    PLoS ONE Alerts: New Articles

  • According to Xconomy, Theraclone formed an alliance last year with the Tokyo-based company, which markets a blockbuster antibody drug for cancer and rheumatoid arthritis called rituximab (Rituxan) in Japan.

    PhysOrg.com - latest science and technology news stories

  • According to Xconomy, Theraclone formed an alliance last year with the Tokyo-based company, which markets a blockbuster antibody drug for cancer and rheumatoid arthritis called rituximab (Rituxan) in Japan.

    PhysOrg.com - latest science and technology news stories

  • According to Xconomy, Theraclone formed an alliance last year with the Tokyo-based company, which markets a blockbuster antibody drug for cancer and rheumatoid arthritis called rituximab (Rituxan) in Japan.

    PhysOrg.com - latest science and technology news stories

  • Under current guidelines, patients qualify for rituximab, which is marketed as MabThera, only on failing to respond to an anti-TNF.

    Food &Health Skeptic

Comments

New comments are temporarily disabled while we update our database.